PRLD vs TECH
Prelude Therapeutics Inc (PRLD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PRLD currently screens at market cap $346.5M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PRLD and TECH stock pages for the full models.
Not investment advice.